Figure 1From: Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situPhospho human epidermal growth factor receptor 2 (pHER2) protein expression. (A) Positive expression before lapatinib treatment. (B) Negative expression after lapatinib treatment.Back to article page